If you suddenly feel short of breath and a bit anxious, it might be something called "dyspnea." Let's dive into what the ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

The primary efficacy endpoint of the APEX-AV trial was the reduction in RV/LV ratio between baseline and 48 hours post-procedure. The primary safety endpoint was the rate of MAEs, including events ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

This communication presents 2 of these cases that illustrate this form of treatment together with ... Although this patient had preexisting chronic pulmonary disease, it was not severe enough ...

MANY clinical and experimental studies have been performed to study the etiology, diagnosis and treatment ... fat embolism," has been recognized. In documenting the first case of pulmonary and ...

A pulmonary embolism is the most common pathology of a pulmonary angiogram. Options for treatment of a pulmonary embolism include: Pulmonary angiography of the lungs involves tests that examine how ...